2009
DOI: 10.1016/j.cellimm.2008.09.002
|View full text |Cite
|
Sign up to set email alerts
|

Activation of Toll-like receptors and dendritic cells by a broad range of bacterial molecules

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
8
0
5

Year Published

2011
2011
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(14 citation statements)
references
References 21 publications
1
8
0
5
Order By: Relevance
“…Pemberian dosis LPS sama dengan beberapa penelitian yaitu pada mencit kurang dari 20µg tidak memberikan respon imun pada dengan memberikan LPS secara intraperitoneal dan mencit sehat (24). Penelitian lain juga menyebutkan dilakukan pemeriksaan pada sel makrofag, menunjukan bahwa dosis LPS yang aman untuk binatang coba adalah peningkatan ekspresi TLR2 dibandingkan TLR4 (4,24) berkisar antara 0,25-2,5 µ/g BB (3,25).…”
Section: Dengan Kontrolunclassified
“…Pemberian dosis LPS sama dengan beberapa penelitian yaitu pada mencit kurang dari 20µg tidak memberikan respon imun pada dengan memberikan LPS secara intraperitoneal dan mencit sehat (24). Penelitian lain juga menyebutkan dilakukan pemeriksaan pada sel makrofag, menunjukan bahwa dosis LPS yang aman untuk binatang coba adalah peningkatan ekspresi TLR2 dibandingkan TLR4 (4,24) berkisar antara 0,25-2,5 µ/g BB (3,25).…”
Section: Dengan Kontrolunclassified
“…In monocytes, intact G+ bacteria induce higher levels of IL-12 and TNF production than do G− bacteria, while the latter induce higher levels of IL-10 and PGE 2 [7], [8], [9], [10]. Conversely, human monocytes that have been differentiated in vitro into dendritic cells (DCs) produce similar levels of IL-12 and TNF in response to G+ and G− bacteria [11], [12], [13]. Furthermore, G− bacteria are more potent than G+ bacteria in promoting the up-regulation of co-stimulatory molecules on monocyte-derived DCs [12], [13].…”
Section: Introductionmentioning
confidence: 99%
“…Conversely, human monocytes that have been differentiated in vitro into dendritic cells (DCs) produce similar levels of IL-12 and TNF in response to G+ and G− bacteria [11], [12], [13]. Furthermore, G− bacteria are more potent than G+ bacteria in promoting the up-regulation of co-stimulatory molecules on monocyte-derived DCs [12], [13]. Presentation of unrelated antigens by DC to T cells is known to be enhanced by bacterial-induced maturation, and, in particular G− bacteria, have been shown to promote Th1 polarisation [13], [14], [15].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…there is therefore an urgent need for new improved adjuvants. the integrated in vitro testing strategy for the development of new adjuvants is comprised of luminescent bioassays for toll-like receptor-mediated responses to assess adjuvanticity (Bsibsi et al, 2010;Boele et al, 2009;Jagessar et al, 2010;Koopman et al, 2013) and 2D/3D in vitro granuloma models to assess adverse effects. Data were shown demonstrating that the sequential use of multiple bioassays as a robust integrated test system can rapidly generate detailed information and can aid the development of new potent adjuvants with minimal adverse effects.…”
Section: Recent Advances In Technology (Crispr/cas9) Now Render It Pomentioning
confidence: 99%